Learn how subcutaneous nivolumab shifts immunotherapy from IV infusions to quick thigh or abdominal injections, approved in late 2024.

Discover how modern immunotherapy awakens T cells to shrink melanoma tumors, tracked by PET scans and used after surgery to prevent relapse. In this segment, Dr. Morrison provides clinical context ...

Mary Bird Perkins Cancer Center in Baton Rouge, Louisiana is offering a CAR-T cell-based immunotherapy, which genetically ...

At 43 years old, and with two young kids under five, Laura Ryan just wanted her cancer treatment to keep her alive, but she ...

Lilit Karapetyan, MD, MS, discusses a single-center trial of reduced-intensity conditioning before tumor-infiltrating ...

Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...

A new study from Stanford researchers reveals a non-invasive urine test that can accurately detect residual bladder cancer ...

Biomarkers are revolutionizing oncology drug development, driving modern precision medicine approaches, targeted clinical trial recruitment strategies, and critical decision-making.

Carina Venter, PhD, RD, received the Allied Health Professionals Recognition Award at this year’s American Academy of Allergy ...

In the spring, when pollen and fine dust are rampant, if you dismiss your symptoms as a common cold but they persist for ...

Fred Hutch at AACR: Colorectal cancer and glyphosate exposure, potential therapeutic targets for ovarian cancer, a new molecular standard of care for cancer patients — and more ...

Nancy has been a health news reporter and editor at Reuters for more than a decade, covering important medical research advances. She is the author of our twice-a-week Reuters Health Rounds newsletter ...